Funded Tech Companies

NewLeaf Symbiotics

Operating out of St. Louis, NewLeaf Symbiotics is venture-backed, with investment from Leaps by Bayer, Otter Capital and S2G Ventures.

Company Overview

Contact Information

Company Background Information

Overview

NewLeaf Symbiotics is a science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/19/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stephen Kahn

        

Chief Scientific Officer

Desmond Jimenez

        

Chief Technical Officer

Janne Kerovuo

        

VP - Bus. Development

Matthew Helms

        

VP - General Counsel

Molly Edwards

        

VP - Manufacturing

Aaron Kelley

        

VP - R & D

Natalie Breakfield

        

Company Investors

• Leaps by Bayer
• Otter Capital
• S2G Ventures
• Gullspang Refood
• Monsanto
• S2G Ventures (Sanjeev Krishnan)
• Monsanto (Ryan Rakestraw)
• Otter Capital (John Pasquesi)
• Pangaea Ventures (Keith Gillard)
• RockPort Capital (Kevin Kopczynski)
• Open Prairie Ventures (Jason Wrone)
• Lewis & Clark Ventures

Browse more funded tech companies:

Newlans | Newlight Technologies

Share this article

About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary